Yahoo Scout
Yahoo Scout
Searching…
Yahoo Scout
Get protection against cyberthreats with Comcast Business SecurityEdge Preferred. Learn how SecurityEdge Preferred has advanced features that help you to focus on business.
“At Vir Biotechnology we engineer antibodies into powerful, impactful medicines, and deliver them to patients who are waiting - fast. We are fueled by the company’s deep capabilities in knowledge of immunology, and ou...
Aug 6, 2024 · Vir Biotechnology 在重大战略调整中,决定停止其大部分病毒学研究,并通过与Sanofi的独家许可协议,转向癌症领域的发展。 Vir Biotechnology 于周四(8 月 1 日)宣布了其战略性改革计划,该计划涉及研发重点的重大转变和全面的结构变革。
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and...
简介:Vir Biotechnology, Inc.于2016年4月7日根据特拉华州法律注册成立。 作为一家临床阶段的生物制药公司,VIR致力于增强免疫系统,以开发针对严重传染病和癌症的创新疗法。 该公司的方法侧重于解决这些威胁逃避免疫防御的复杂机制。
提供Vir Biotechnology (VIR)实时行情数据;汇总Vir Biotechnology (VIR)基本资料及重大新闻、研究报告及行业资讯,解读Vir Biotechnology (VIR)主力资金动向、财务数据,为投资Vir Biotechnology (VIR)提供参考决策
亿欧数据为您提供VIR BIOTECHNOLOGY INC的主营业务、公司简介、企业官网、公司地址、招聘信息、财务信息、融资情况、团队信息、电话号码、招投标信息、专利等多维度详细信息查询,帮您全面了解Vir Biotechnology经营情况
Feb 24, 2026 · Download PDF, Vir Biotechnology Announces Proposed Public Offering of Common Stock, February 24, 2026, (opens in new window)
Get protection against cyberthreats with Comcast Business SecurityEdge Preferred. Learn how SecurityEdge Preferred has advanced features that help you to focus on business.